Searching for High-Risk Venous Thromboembolism Patients Using Risk Scores: Adding to the Heap or Closing a Gap?

Ida Ehlers Albertsen; Peter Brønnum Nielsen

doi:10.1055/s-0038-1673330

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 2018; 118(10): 1686-1687
DOI: 10.1055/s-0038-1673330

Invited Editorial Focus

Georg Thieme Verlag KG Stuttgart · New York

Searching for High-Risk Venous Thromboembolism Patients Using Risk Scores: Adding to the Heap or Closing a Gap?

Authors

Ida Ehlers Albertsen

¹Department of Cardiology, Aalborg University Hospital, Aalborg University, Aalborg, Denmark

²Aalborg Thrombosis Research Unit, Aalborg University, Aalborg, Denmark
Peter Brønnum Nielsen

¹Department of Cardiology, Aalborg University Hospital, Aalborg University, Aalborg, Denmark

²Aalborg Thrombosis Research Unit, Aalborg University, Aalborg, Denmark

Abstract

Full Text

References

References
1 Falck-Ytter Y, Francis CW, Johanson NA. , et al. Prevention of VTE in orthopedic surgery patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141: e278S-e325S
2 Nemeth B, van Adrichem R, van Hylckama Vlieg A. , et al. Venous thrombosis risk after arthroscopy of the knee: derivation and validation of the L-TRiP(ascopy) score. Thromb Haemost 2018; 118 (10) 1823-1831
3 ISTH Steering Committee for World Thrombosis Day. Venous thromboembolism: a call for risk assessment in all hospitalised patients. Thromb Haemost 2016; 116 (05) 777-779
4 Crous-Bou M, De Vivo I, Camargo Jr CA. , et al. Interactions of established risk factors and a GWAS-based genetic risk score on the risk of venous thromboembolism. Thromb Haemost 2016; 116 (04) 705-713
5 Steyerberg EW, Vergouwe Y. Towards better clinical prediction models: seven steps for development and an ABCD for validation. Eur Heart J 2014; 35 (29) 1925-1931
6 Collins GS, Reitsma JB, Altman DG, Moons KGM. ; members of the TRIPOD group. Transparent Reporting of a Multivariable Prediction Model for Individual Prognosis or Diagnosis (TRIPOD): the TRIPOD Statement. Eur Urol 2015; 67 (06) 1142-1151
7 Gould MK, Garcia DA, Wren SM. , et al. Prevention of VTE in nonorthopedic surgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141: e227S-e277S
8 Kearon C, Ageno W, Cannegieter SC, Cosmi B, Geersing GJ, Kyrle PA. ; Subcommittees on Control of Anticoagulation, and Predictive and Diagnostic Variables in Thrombotic Disease. Categorization of patients as having provoked or unprovoked venous thromboembolism: guidance from the SSC of ISTH. J Thromb Haemost 2016; 14 (07) 1480-1483
9 Schulman S. Accumulating data on rivaroxaban for venous thromboembolism in clinical practice. Thromb Haemost 2017; 117 (10) 1840
10 Goldhaber SZ, Schulman S, Eriksson H. , et al. Dabigatran versus Warfarin for Acute Venous Thromboembolism in Elderly or Impaired Renal Function Patients: Pooled Analysis of RE-COVER and RE-COVER II. Pooled analysis of RE-COVER and RE-COVER II. Thromb Haemost 2017; 117 (11) 2045-2052
11 Schulman S, Ageno W, Konstantinides SV. Venous thromboembolism: past, present and future. Thromb Haemost 2017; 117 (07) 1219-1229
12 Albertsen IE, Nielsen PB, Søgaard M. , et al. Venous thromboembolism and risk of recurrence: a Danish Nationwide Cohort Study. Am J Med 2018;